News - AIVITA Biomedical

AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote on AI in Healthcare at McKenna Institute Digital Innovation Summit

IRVINE, Calif. – Jun. 12, 2023 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Biomedical CEO Dr. Hans Keirstead to Chair Keynote Panel and Present at World Vaccine Congress

IRVINE, Calif. – Apr. 4, 2023 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Biomedical CEO Dr. Hans Keirstead to Present at Abundance360

IRVINE, Calif. – Mar. 20, 2023 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Biomedical Chief Medical Officer Dr. Robert Dillman to Deliver Keynote at World Immunotherapy Congress

IRVINE, Calif. – Mar. 16, 2023 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Biomedical CEO Dr. Hans Keirstead Joins Human Immunome Project Board of Directors

IRVINE, Calif. – Jan. 9, 2023 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

TAE Life Sciences and AIVITA Biomedical Announce Strategic Partnership to Advance Development of Target Boron Drugs for Glioblastoma

FOOTHILL RANCH, Calif.— January 4, 2023—TAE Life Sciences (TLS), a biological-targeted radiation therapy company developing next-generation boron neutron capture therapy…

AIVITA Biomedical Chief Medical Officer Dr. Robert O. Dillman to Deliver Keynote and Chair Cancer Immunotherapy Track at World Vaccine and Immunotherapy Congress

IRVINE, Calif. – Nov. 29, 2022 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…